Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2010
07/27/2010CA2338989C Antibodies for detecting microorganisms
07/27/2010CA2332829C Vaccine delivery system
07/27/2010CA2323091C Nephrin gene and protein
07/27/2010CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
07/27/2010CA2263152C Immunologically active proteins from borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
07/27/2010CA2231801C Conjugates of a polypeptide and a biocompatible polymer
07/27/2010CA2224080C Relaxin-like factor and methods and uses thereof
07/27/2010CA2223300C Expression of lipoproteins
07/27/2010CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems
07/23/2010CA2691041A1 Protein mixtures for maize insect control
07/22/2010WO2010082184A1 New process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn)
07/22/2010WO2010081971A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
07/22/2010WO2010081897A1 Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products
07/22/2010WO2010081890A1 Anti-kir3d antibodies
07/22/2010WO2010081878A1 Mutated antithrombins, a process for preparing the same and their use as drugs
07/22/2010WO2010081875A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
07/22/2010WO2010081492A1 Melanocortin analogs with antimicrobial activity
07/22/2010WO2010062995A3 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
07/22/2010WO2010061283A3 Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
07/22/2010WO2010057882A3 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
07/22/2010WO2010056970A3 Optically-based stimulation of target cells and modifications thereto
07/22/2010WO2010044889A3 Torque teno virus (ttv) isolates and compositions
07/22/2010WO2010040023A3 Methods and compositions for protein delivery
07/22/2010WO2010037135A3 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them
07/22/2010WO2010037063A3 Plasmodium vaccines, antigens, compositions and methods
07/22/2010WO2010024897A3 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
07/22/2010WO2010018378A3 Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy
07/22/2010WO2010014830A4 Peptide therapeutics that bind vegf and methods of use thereof
07/22/2010WO2010003225A8 Influenza virus-like particles (vlps) comprising hemagglutinin
07/22/2010WO2009140659A3 Treating dyspnea associated with acute heart failure with relaxin
07/22/2010WO2009129311A3 Somatostatin receptor 2 antagonists
07/22/2010WO2009055454A3 Xylan-utilization regulon for efficient bioprocessing of hemicellulose and uses thereof
07/22/2010US20100186123 Suppression of Resistance in Insects to Bacillus Thuringiensis Cry Toxins, Using Toxins that do not Require the Cadherin Receptor
07/22/2010US20100186114 Modification of Plant Flavonoid Metabolism
07/22/2010US20100186112 Novel Environmental Stress Resistance Transcription Factor and Method For Enhancing Environmental Stress Resistance of Plants Using the Same
07/22/2010US20100186111 Gene cluster of prenyl transferase from hevea brasiliensis
07/22/2010US20100186110 Yield enhancement in plants by modulation of garp transcripton factor zmrr10_p
07/22/2010US20100186100 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
07/22/2010US20100186099 Production of Human Glycosylated Proteins in Silk Worm
07/22/2010US20100185419 Algorithm for designing irreversible inhibitors
07/22/2010US20100184961 Methods and compositions related to chromatin-associated proteins and other factors
07/22/2010US20100184957 Porous base matrix having formyl group, adsorbent using the porous base matrix, method for production of the porous base matrix, and method for production of the adsorbent
07/22/2010US20100184956 Production of 2s canola protein involving ion exchange
07/22/2010US20100184955 Anticancer prodrug sensitive to target protease
07/22/2010US20100184954 Monomeric red fluorescent proteins
07/22/2010US20100184953 Stable lipid-comprising drug delivery complexes and methods for their production
07/22/2010US20100184951 Truncated BAFF Receptors
07/22/2010US20100184950 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
07/22/2010US20100184949 Method for the mass expression of an antimicrobial peptide by using a translational coupling system
07/22/2010US20100184948 Molecules for targeting compounds to various selected organs or tissues
07/22/2010US20100184836 Vaccine
07/22/2010US20100184697 Peptide-based stat inhibitor
07/22/2010US20100184693 Methods and systems for generating and evaluating peptides
07/22/2010US20100184687 Purification of Glucagon-Like Peptides
07/22/2010US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer
07/22/2010US20100184684 Antibacterial and antifungal peptides
07/22/2010US20100184683 Antibacterial and antifungal peptides
07/22/2010US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses
07/22/2010US20100184681 Antibacterial and antifungal peptides
07/22/2010US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent
07/22/2010US20100184676 Use of a peptide as a therapeutic agent
07/22/2010US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
07/22/2010US20100184671 Binding molecules for the treatment of myeloid cell malignancies
07/22/2010US20100184669 Compositions and methods for cancer treatment using targeted carbon nanotubes
07/22/2010US20100184668 method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments
07/22/2010US20100184667 Modified plasminogen activator inhibitor type-1 molecule and methods based thereon
07/22/2010US20100184665 Method for activating receptor by cofactor and method for utilizing ligand activity
07/22/2010US20100184662 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
07/22/2010US20100184660 Single exon genes encoding for novel bio-active peptides
07/22/2010US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
07/22/2010US20100184657 Methods of treating epithelial lesions outside the stomach and intestines
07/22/2010US20100184656 Pantropic neurotrophic factors
07/22/2010US20100184655 Modified erythropoietin
07/22/2010US20100184654 Anti-microbial targeting chimeric pharmaceutical
07/22/2010US20100184653 Derivates of Polyethylene Glycol Modified Thymosin Alpha 1
07/22/2010US20100184652 Peptide inhibitors of abl kinases
07/22/2010US20100184651 Targeted fusion proteins for cancer therapy
07/22/2010US20100184644 Mucosal repair by tff dimer peptides
07/22/2010US20100184642 Transgenic Plants Expressing Cobalamin Binding Proteins
07/22/2010US20100184641 Novel Plasma Protein Affinity Tags
07/22/2010US20100184639 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
07/22/2010US20100184638 Galanin Receptors and Brain Injury
07/22/2010US20100184619 Method for analyzing organelle-localized protein and material for analysis
07/22/2010US20100184597 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
07/22/2010US20100184236 Guanosine triphosphate (gtp)-binding protein-coupled receptor protein, bg37
07/22/2010US20100184230 Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
07/22/2010US20100184224 Plant cell wall loosening activity of group 2/3 allergens of grass pollen
07/22/2010US20100184223 Biomaterial based on a hydrophilic polymeric carrier
07/22/2010US20100184211 Tumour-Associated Peptides that Bind to MHC Molecules
07/22/2010US20100184184 Production of Conjugates
07/22/2010US20100184183 Collagen scaffold modified by covalent grafting of adhesion molecules, associated methods and use thereof for cardiovascular and thoracic cell therapy and contractile tissue engineering
07/22/2010US20100184156 Recombinant Colwellia Psychrerythraea Alkaline Phosphatase and Uses Thereof
07/22/2010US20100184142 DNA sequences coding a translocon ATPase and a intramolecular regulator of ATP hydrolysis regulatory sequence for use in vector in order to enhance expression and transport of heterologous gene and polypeptides
07/22/2010US20100184139 BASB082 polynucleotides
07/22/2010US20100184116 Fluorescent protein
07/22/2010US20100184111 comprising N-{3-(hydroxyaminocarbonyl)-1-oxo-(2R)-benzylpropyl}-Ile-Leu-OH as in catalytic domain of modified tumor necrosis factor-alpha converting enzyme; less susceptible to autoproteolysis; drug design; host cells; computers
07/22/2010US20100184106 Thrombin Substrate and Assay for Determining the Level of Bioactive Thrombin in a Sample
07/22/2010US20100184096 Screening methods using sitosterolemia susceptibility gene (ssg) polypeptides
07/22/2010US20100184094 Use of mdck cells in the evaluation of cholesterol modulators
07/22/2010US20100184091 Method for determining MIF content